Industry & Policy News

[Boston University] Julie Palmer, ScD, co-director of the Boston University-Boston Medical Center Cancer Center, has been awarded a one-year, $589,000 Research Grant from the Breast Cancer Research Foundation for her research, “Breast Cancer Drivers in Black Women: Society to Cells.”

[Hepion Pharmaceuticals, Inc.] Hepion Pharmaceuticals, Inc. announced additional efficacy data for rencofilstat, its lead drug candidate for the treatment of metabolic dysfunction-associated steatohepatitis, fibrotic diseases, hepatocellular carcinoma, and other chronic diseases.

[Memorial Sloan Kettering Cancer Center] Memorial Sloan Kettering Cancer Center has announced three innovative investigators as the recipients of this year’s Paul Marks Prize for Cancer Research.

[The University of Tennessee Health Science Center] Colleen Jonsson, PhD, director of the Regional Biocontainment Laboratory (RBL) at the University of Tennessee Health Science Center, has been awarded $11.9 million from the National Institute of Allergy and Infectious Diseases to expand and improve the RBL infrastructure.

[Nature] Article-processing charges levied by publishers on authors have become an integral — and sometimes unpopular — part of the open-access revolution. Other options are being explored.

[STAT News] The explosive national demand for weight management therapies and diabetes drugs like Ozempic — all of which are indicated for indefinite use — has become central in an ongoing policy debate over high drug costs and controversial tactics to manage them, including President Biden’s plan to let the government negotiate directly with pharmaceutical companies.